Paragraph 1

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Sch 3, Pt II, para 1 am by Medicines (Products for Animal Use—Fees) 2001 regs 2(3)(a), 3
Sch 3, Pt II, para 2 am by Medicines (Products for Animal Use—Fees) 2001 regs 2(3)(b), 3
Sch 3, Pt III am by Medicines (Products for Animal Use—Fees) 2001 regs 2(3)(c), 3
Sch.3, Pt.II, para.1 amended by Medicines (Products for Animal Use—Fees) 1999 reg.3(1)(a)
Sch.3, Pt.II, para.2 amended by Medicines (Products for Animal Use—Fees) 1999 reg.3(1)(b)
Sch.3, Pt.III amended by Medicines (Products for Animal Use—Fees) 1999 reg.3(1) (c)
regs 12,13.14. Sch 1. Pt.II, paras.1 -3,6-9, Pt.III. paras 4,5, Pt.IV, paras.1- 3,5-7, Pt.V, paras.1 -3. Sch.2. paras.2.3 amended by Medicines (Products for Animal Use—Fees) 2000 reg.2. Sch.
Sch.3, Pt.II, para.2 amended by Medicines (Products for Animal Use—Fees) 2000 reg.3(1)(b)
Sch.3, Pt.III amended by Medicines (Products for Animal Use—Fees) 2000 reg.3(1)(c)
Sch 3, Pt II, para 1 am by Medicines (Products for Animal Use—Fees) 2003 regs 3(1), (3), 4
Sch 3, Pt II am by Medicines (Products for Animal Use—Fees) 2002 regs 2(2), 3

In the case of a business with a turnover of £2,800,000 or over, the fee payable shall, subject to paragraph 4 and Part III of this Schedule, be £248 for each marketing authorisation or product licence held, plus £17,640 plus 0.42% of annual turnover in excess of £2,800,000.